Issue link: https://www.e-digitaleditions.com/i/1087673
10 March 2019 Tablets & Capsules W hen developing a pediatric-focused drug product, pharmaceutical companies are faced with additional chal- lenges than when developing a product for adults. It's insufficient merely to think of children as small adults and scale the dose down based on a child's body weight. A pediatric dosage form must be safe, effective, palat- able, and easy to administer. It must minimize dosing fre- quency and allow sufficient flexibility to meet children's needs at various stages of development. Also, it's critical While tablets and capsules are often the preferred dosage forms of both patients and pharmaceutical companies, they can be difficult to swallow for children. This article presents the chal- lenges associated with developing pediatric solid oral dosage forms (SODFs), discusses some alternatives, and describes efforts to develop more patient-centric pediatric drug products. Developing pediatric dosage forms Uwe Hanenberg, Pascale Clement, and William Wei Lim Chin Catalent dosage form